Empresa American BriVision (Holding) Corporation OTC Markets
Acciones
ABVC
US0247332069
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | - | 23/06/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01/03/21 |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10/07/22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23/11/17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23/11/17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23/11/17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Hsin-Hui Miao
BRD | Director/Board Member | 57 | 04/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 10 878 376 | 8 003 326 ( 73,57 %) | 26 553 ( 0,2441 %) | 73,57 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M | |
+77,64 % | 8873,08 M |